Hikma debuts thiamine hydrochloride injection

Hikma is introducing thiamine hydrochloride injection.

The medication is indicated for the treatment of thiamine deficiency or beriberi. It is used to treat both the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety.

Thiamine hydrochloride injection had a market value of approximately $33 million in the 12 months ended November 2020, according to IQVIA.